EAM
EPIX

Eventide Asset Management’s ESSA Pharma EPIX Stock Holding History

Eventide Asset Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,561,251
Closed -$2.84M – 149
2022
Q3 		$2.84M Sell
1,561,251
-1,804,317
-54% -$4.75M 0.06% 131
2022
Q2 		$10.6M Sell
3,365,568
-804,691
-19% -$4.5M 0.23% 96
2022
Q1 		$25.8M Buy
4,170,259
+851,612
+26% +$7.49M 0.4% 75
2021
Q4 		$47.1M Buy
3,318,647
+1,137,546
+52% +$12.7M 0.6% 56
2021
Q3 		$17.4M Sell
2,181,101
-224,068
-9% -$3.56M 0.23% 105
2021
Q2 		$68.7M Hold
2,405,169
– – 0.92% 40
2021
Q1 		$69.9M Buy
2,405,169
+70,000
+3% +$1.63M 1.04% 35
2020
Q4 		$26.5M Hold
2,335,169
– – 0.41% 78
2020
Q3 		$15.3M Buy
2,335,169
+325,000
+16% +$2.21M 0.31% 91
2020
Q2 		$11.8M Hold
2,010,169
– – 0.27% 89
2020
Q1 		$7.64M Hold
2,010,169
– – 0.26% 91
2019
Q4 		$10.5M Hold
2,010,169
– – 0.3% 78
2019
Q3 		$6.44M Buy
2,010,169
+625,000
+45% +$1.54M 0.21% 82
2019
Q2 		$3.22M Buy
1,385,169
+903,198
+187% +$2.23M 0.1% 91
2019
Q1 		$1.65M Buy
481,971
+1
+0% +$4 0.06% 107
2018
Q4 		$1.01M Hold
481,970
– – 0.04% 117
2018
Q3 		$1.49M Sell
481,970
-1
-0% -$3 0.05% 126
2018
Q2 		$1.82M Hold
481,971
– – 0.08% 117
2018
Q1 		$1.83M Buy
481,971
+346,000
+254% +$1.44M 0.09% 116
2017
Q4 		$576K Hold
135,971
– – 0.03% 136
2017
Q3 		$699K Hold
135,971
– – 0.04% 126
2017
Q2 		$1.31M Hold
135,971
– – 0.08% 109
2017
Q1 		$7.41M Hold
135,971
– – 0.49% 57
2016
Q4 		$5.26M Hold
135,971
– – 0.34% 69
2016
Q3 		$6.83M Hold
135,971
– – 0.42% 64
2016
Q2 		$7.37M Hold
135,971
– – 0.45% 62
2016
Q1 		$7.83M Buy
+135,971
New +$8.87M 0.44% 62

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ABG
Ally Bridge Group New York $101M AUM 249.88% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return